Correction: Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2

Ruichao Mao; Lihua Bie; Maofeng Xu; Xiaocong Wang; Jun Gao

doi:10.1039/d1cp90113c

Correction: Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2

Phys Chem Chem Phys. 2021 Jun 9;23(22):12907. doi: 10.1039/d1cp90113c.

Authors

Ruichao Mao¹, Lihua Bie¹, Maofeng Xu¹, Xiaocong Wang¹, Jun Gao¹

Affiliation

¹ Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan, Hubei 430070, China. gaojun@mail.hzau.edu.cn.

PMID: 34046655
DOI: 10.1039/d1cp90113c

Abstract

Correction for 'Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2' by Ruichao Mao et al., Phys. Chem. Chem. Phys., 2021, DOI: 10.1039/d1cp01045j.

Publication types

Published Erratum